IP Verse

Phosphorous Derivatives As Kinase Inhibitors - EP2300013

The patent EP2300013 was granted to Ariad Pharmaceuticals on Nov 13, 2024. The application was originally filed on May 21, 2009 under application number EP09751617A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2300013

ARIAD PHARMACEUTICALS
Application Number
EP09751617A
Filing Date
May 21, 2009
Status
Patent Maintained As Amended
Oct 11, 2024
Grant Date
Nov 13, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKJun 5, 2018ELKINGTON AND FIFEADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONFR2911138
EXAMINATIONWO2004080980
EXAMINATIONWO2007021937
INTERNATIONAL-SEARCH-REPORTUS2005203114
INTERNATIONAL-SEARCH-REPORTUS6770652
INTERNATIONAL-SEARCH-REPORTUS6878697
OPPOSITIONFR2911138
OPPOSITIONUS2004242611
OPPOSITIONUS2005203114
OPPOSITIONWO2004080980
OPPOSITIONWO2005016528
OPPOSITIONWO2006078846
OPPOSITIONWO2007006926
OPPOSITIONWO2007021937
SEARCHUS2005203114
SEARCHUS6878697
SEARCHWO2005016528
SEARCHWO2006078846
SEARCHWO2007006926

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- BRUNING et al., "Role of Brain Insulin Receptor in Control of Body Weight and Reproduction", Science, (20000922), vol. 22, pages 2122 - 2125, XP055499036-
OPPOSITION- CORTEZ et al., "Common mechanisms of PIKK regulation", DNA Repair, (20090000), vol. 8, pages 1004 - 1008, XP026446528-
OPPOSITION- KAHN et al., "Loss of insulin signalling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction", Molecular Cell, (20000000), vol. 6, pages 87 - 97, XP055499037-
OPPOSITION- KAMER et al., "Wide Bite Angle Diphosphines: Xantphos Ligands in Transition Metal Complexes and Catalysis", Acc. Chem. Res., (20010000), vol. 34, pages 895 - 904, XP055499103-
OPPOSITION- FIAUD et al., "Synthesis of Enantiopure 1-r-Aryl-2-c,5-t-diphenylphospholane oxides and boranes by Pd-Catalyzed C-P Bond Formation", Eur. J. Org. Chem., (20060000), pages 650 - 656, XP055499101
OPPOSITION- MASS, "The HER receptor family: a rich target for therapeutic development", Int. J. Radiation Oncology Biol. Phys., (20040000), vol. 58, pages 932 - 940, XP008060823
OPPOSITION- FABBRO et al., "Protein kinases as targets for anticancer agents: from inhibitors to useful drugs", Pharmacology and Therapeutics, (20020000), vol. 93, pages 79 - 98, XP002350189
OPPOSITION- GALKIN et al., "Identification of NVP-TAE684, a potent, selective and efficacious Inhibitor of NPM-ALK", PNAS, (20070102), vol. 104, no. 1, pages 270 - 275, XP002661293
OPPOSITION- KITAMURA et al., "Insulin Receptor Knockout Mice", Annu. Rev. Physiol., (20030000), vol. 65, pages 313 - 332, XP055499041
OPPOSITION- PICCALUGA et al., "Imatinib mesylate in the treatment of hematologic malignancies", Expert Opin. Biol. Ther., (20070000), vol. 7, no. 10, pages 1597 - 1611, XP055499048

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents